Factors influencing Thai university students' decisions to take COVID-19 vaccine booster doses: a cross-sectional survey
- PMID: 38632632
- PMCID: PMC11022483
- DOI: 10.1186/s41182-024-00597-1
Factors influencing Thai university students' decisions to take COVID-19 vaccine booster doses: a cross-sectional survey
Abstract
Background: We aimed to describe the acceptance of COVID-19 vaccine booster doses and factors influencing this among Thai university students.
Methods: A cross-sectional survey was conducted between July and September 2022. All university students in Thailand were eligible to participate. We explored the acceptance rate of COVID-19 vaccine booster doses and regular vaccines (if available) among university students. Associations between factors influencing the acceptance of vaccination were analyzed by multiple logistic regression analysis.
Results: A total of 322 participants were surveyed (78.9% female, age 18 to 49 years (mean = 22.6, standard deviation = 5.47)). Most participants (85.7%) were undergraduate students (Bachelor level), and a proportion (84.8%) had a background in health sciences studies. The proportions who accepted booster doses and regular vaccines were 52.8% and 69.3%, respectively. Vaccine accessibility was found to be significantly associated with the acceptance of booster doses (adjusted odds ratio (AOR) = 2.77, 95% confidence interval (CI) = 1.10-6.97), while the availability of scientific evidence (AOR = 3.44, 95% CI = 1.21-9.77) was significantly associated with the acceptance of regular vaccines.
Conclusions: This study contributes to addressing the knowledge gap regarding acceptance of COVID-19 vaccine booster doses among university students in Thailand. Our findings revealed that vaccine accessibility and the availability of scientific evidence, as well as vaccination costs, influenced individuals' decisions around accepting vaccine booster doses. Further research should focus on the dynamics of vaccine acceptance to facilitate the development of targeted strategies and support vaccination policymaking in Thailand.
Keywords: Booster doses; COVID-19 vaccine; Public health; Vaccine acceptance.
© 2024. The Author(s).
Conflict of interest statement
The authors have no financial and non-financial competing interests to declare for this study.
Similar articles
-
Factors influencing the third COVID-19 vaccine booster dose acceptance among older adults in northern Thailand.BMC Infect Dis. 2024 Sep 2;24(1):897. doi: 10.1186/s12879-024-09785-0. BMC Infect Dis. 2024. PMID: 39223501 Free PMC article.
-
Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.Int J Environ Res Public Health. 2022 Sep 25;19(19):12136. doi: 10.3390/ijerph191912136. Int J Environ Res Public Health. 2022. PMID: 36231447 Free PMC article.
-
Acceptance of Booster COVID-19 Vaccine and Its Association with Components of Vaccination Readiness in the General Population: A Cross-Sectional Survey for Starting Booster Dose in Japan.Vaccines (Basel). 2022 Jul 8;10(7):1102. doi: 10.3390/vaccines10071102. Vaccines (Basel). 2022. PMID: 35891266 Free PMC article.
-
Acceptance of COVID-19 vaccination during pregnancy among Thai pregnant women and their spouses: a prospective survey.Reprod Health. 2022 Mar 24;19(1):74. doi: 10.1186/s12978-022-01383-0. Reprod Health. 2022. PMID: 35331263 Free PMC article.
-
COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis.Trop Med Infect Dis. 2022 Oct 13;7(10):298. doi: 10.3390/tropicalmed7100298. Trop Med Infect Dis. 2022. PMID: 36288039 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19). 2022. https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19.html. Accessed 15 July 2023
-
- World Health Organization (WHO). Coronavirus disease (COVID-19). 2022. https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed 15 Jul 2023
-
- Adams K, Rhoads JP, Surie D, Gaglani M, Ginde AA, McNeal T, Talbot HK, Casey JD, Zepeski A, Shapiro NI, et al. Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. BMJ. 2022;379:e072065. doi: 10.1136/bmj-2022-072065. - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention (CDC). Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated—VISION Network, 10 States, December 2021–June 2022. 2022. https://www.cdc.gov/mmwr/volumes/71/wr/mm7129e1.htm. Accessed 9 Mar 2024 - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous